Literature DB >> 21167323

Structure, mechanism, and substrate specificity of kynureninase.

Robert S Phillips1.   

Abstract

The kynurenine pathway is the major route for tryptophan catabolism in animals and some fungi and bacteria. The procaryotic enzyme preferentially reacts with l-kynurenine, while eucaryotic kynureninases exhibit higher activity with 3-hydroxy-l-kynurenine. Crystallography of kynureninases from Pseudomonas fluorescens (PfKyn) and Homo sapiens (HsKyn) shows that the active sites are nearly identical, except that His-102, Asn-333, and Ser-332 in HsKyn are replaced by Trp-64, Thr-282, and Gly-281 in PfKyn. Site-directed mutagenesis of HsKyn shows that these residues are, at least in part, responsible for the differences in substrate specificity since the H102W/S332G/N333T triple mutant shows activity with kynurenine but not 3-hydroxykynurenine. PfKyn is strongly inhibited by analogs of a proposed gem-diolate intermediate, dihydrokynurenine, and S-(2-aminophenyl)-l-cysteine S,S-dioxide, with K(i) values in the low nanomolar range. Stopped-flow kinetic experiments show that a transient quinonoid intermediate is formed on mixing, which decays to a ketimine at 740 s(-1). Quench experiments show that anthranilate, the first product, is formed in a stoichiometric burst at 50 s(-1) and thus the rate-determining step in the steady-state is the release of the second product, l-Ala. β-Benzoylalanine is also a good substrate for PfKyn but does not show a burst of benzoate formation, indicating that the rate-determining step for this substrate is benzoate release. A Hammett plot of rate constants for substituted β-benzoylalanines is non-linear, suggesting that carbonyl hydration is rate-determining for electron-donating groups, but C(β)-C(γ) cleavage is rate-determining for electron-withdrawing groups. This article is part of a Special Issue entitled: Pyridoxal phosphate Enzymology.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167323      PMCID: PMC3102132          DOI: 10.1016/j.bbapap.2010.12.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

1.  2-Amino-4-[3'-hydroxyphenyl]-4-hydroxybutanoic acid; a potent inhibitor of rat and recombinant human kynureninase.

Authors:  Harold A Walsh; Pauline L Leslie; Karen C O'Shea; Nigel P Botting
Journal:  Bioorg Med Chem Lett       Date:  2002-02-11       Impact factor: 2.823

2.  Crystalline kynureninase from Pseudomonas marginalis.

Authors:  M Moriguchi; T Yamamoto; K Soda
Journal:  Biochem Biophys Res Commun       Date:  1971-08-06       Impact factor: 3.575

3.  Homology of pyridoxal-5'-phosphate-dependent aminotransferases with the cobC (cobalamin synthesis), nifS (nitrogen fixation), pabC (p-aminobenzoate synthesis) and malY (abolishing endogenous induction of the maltose system) gene products.

Authors:  P K Mehta; P Christen
Journal:  Eur J Biochem       Date:  1993-01-15

4.  Substituent effects on the reaction of beta-benzoylalanines with Pseudomonas fluorescens kynureninase.

Authors:  Sunil Kumar; Vijay B Gawandi; Nicholas Capito; Robert S Phillips
Journal:  Biochemistry       Date:  2010-09-14       Impact factor: 3.162

5.  Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.

Authors:  M P Heyes; B J Brew; K Saito; B J Quearry; R W Price; K Lee; R B Bhalla; M Der; S P Markey
Journal:  J Neuroimmunol       Date:  1992-09       Impact factor: 3.478

6.  Three-dimensional structure of kynureninase from Pseudomonas fluorescens.

Authors:  Cory Momany; Vladimir Levdikov; Lena Blagova; Santiago Lima; Robert S Phillips
Journal:  Biochemistry       Date:  2004-02-10       Impact factor: 3.162

7.  Differential effects of bromination on substrates and inhibitors of kynureninase from Pseudomonas fluorescens.

Authors:  Christian Heiss; Jay Anderson; Robert S Phillips
Journal:  Org Biomol Chem       Date:  2003-01-21       Impact factor: 3.876

8.  Reaction of Pseudomonas fluorescens kynureninase with beta-benzoyl-L-alanine: detection of a new reaction intermediate and a change in rate-determining step.

Authors:  Vijay B Gawandi; Diane Liskey; Santiago Lima; Robert S Phillips
Journal:  Biochemistry       Date:  2004-03-23       Impact factor: 3.162

9.  Detection of beta-carbanion formation during kynurenine hydrolysis catalyzed by Pseudomonas marginalis kynureninase.

Authors:  G S Bild; J C Morris
Journal:  Arch Biochem Biophys       Date:  1984-11-15       Impact factor: 4.013

10.  Aminotransferases: demonstration of homology and division into evolutionary subgroups.

Authors:  P K Mehta; T I Hale; P Christen
Journal:  Eur J Biochem       Date:  1993-06-01
View more
  11 in total

Review 1.  Targeting TDO in cancer immunotherapy.

Authors:  Cheng-Peng Yu; Yun-Lei Song; Zheng-Ming Zhu; Bo Huang; Ying-Qun Xiao; Da-Ya Luo
Journal:  Med Oncol       Date:  2017-03-29       Impact factor: 3.064

2.  Direct observation of intermediates in the SufS cysteine desulfurase reaction reveals functional roles of conserved active-site residues.

Authors:  Matthew Blahut; Courtney E Wise; Michael R Bruno; Guangchao Dong; Thomas M Makris; Patrick A Frantom; Jack A Dunkle; F Wayne Outten
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

3.  A substrate-assisted mechanism of nucleophile activation in a Ser-His-Asp containing C-C bond hydrolase.

Authors:  Antonio C Ruzzini; Shiva Bhowmik; Subhangi Ghosh; Katherine C Yam; Jeffrey T Bolin; Lindsay D Eltis
Journal:  Biochemistry       Date:  2013-10-09       Impact factor: 3.162

4.  B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study.

Authors:  Barton F Haynes; Garnett Kelsoe; Stephen C Harrison; Thomas B Kepler
Journal:  Nat Biotechnol       Date:  2012-05-07       Impact factor: 54.908

Review 5.  TDO as a therapeutic target in brain diseases.

Authors:  Cheng-Peng Yu; Ze-Zheng Pan; Da-Ya Luo
Journal:  Metab Brain Dis       Date:  2016-04-13       Impact factor: 3.584

Review 6.  Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.

Authors:  Ping Song; Tharmarajan Ramprasath; Huan Wang; Ming-Hui Zou
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

7.  Involvement of the kynurenine pathway in human glioma pathophysiology.

Authors:  Seray Adams; Charles Teo; Kerrie L McDonald; Anna Zinger; Sonia Bustamante; Chai K Lim; Gayathri Sundaram; Nady Braidy; Bruce J Brew; Gilles J Guillemin
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

8.  Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.

Authors:  Perrine Bortolotti; Benjamin Hennart; Camille Thieffry; Guillaume Jausions; Emmanuel Faure; Teddy Grandjean; Marion Thepaut; Rodrigue Dessein; Delphine Allorge; Benoit P Guery; Karine Faure; Eric Kipnis; Bertrand Toussaint; Audrey Le Gouellec
Journal:  BMC Microbiol       Date:  2016-07-08       Impact factor: 3.605

Review 9.  Pyridoxal 5'-Phosphate-Dependent Enzymes at the Crossroads of Host-Microbe Tryptophan Metabolism.

Authors:  Barbara Cellini; Teresa Zelante; Mirco Dindo; Marina M Bellet; Giorgia Renga; Luigina Romani; Claudio Costantini
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 10.  Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology.

Authors:  Jennifer M Parrott; Jason C O'Connor
Journal:  Front Psychiatry       Date:  2015-08-20       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.